
|Articles|July 20, 2021
Novotech Joins DTRA
Advertisement
Novotech Health Holdings Pte. Ltd. (“Novotech”) has joined an alliance of over one hundred life sciences and healthcare organizations that seek to accelerate the broad adoption of patient-focused, decentralized trials, and research. The “Decentralized Trials & Research Alliance (DTRA),” launched in December 2020, is uniting industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Lab Orchestration Is Not What You Think It Is
2
Why Seizure Counts Alone Can't Define Success in Epilepsy Trials
3
ACT Brief: Patient Voice in Protocol Design, AI-Informed Recruitment Workflows, and Engagement Maturity Beyond Performative
4
What It Actually Means to Embed the Patient Voice in Trial Design
5




